2Martin PH,Murthy BV,Petros AJ.Metabolic,biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care.Br J Anaesth,1997,79:276-279.
3Gottardis M,Khunl-Brady KS,Koller W,et al.Effect of prolonged sedation with propofol on serum triglyceride and cholesterol concentrations.Br J Anaesth,1989,62:393-396.
4Ewart MC,Yau KW,Morgan M.2% propofol for sedation in the intensive care unit,A feasibility study.Anaesthesia,1992,47:146-148.
5Albrecht S,Ihmsen H,Suchodolski K.Analgo-sedation in intensive care:a quantitative,EEG-based trial with propofol 1% and 2%.Anaesthesist,1999,48:794-801.
6Prins SA,Peeters MY,Houmes RJ,et al.Propofol 6% as sedative in children under 2 years of age following major craniofacial surgery.Br J Anaesth,2005,945:630-635.
8Vanlander AV, Jorens PG, Smet J, et al. Inborn oxidative phosphogylation defect as risk factor for propofol infusion syn- drome[ J ]. Acta Anaesthesiol Scand, 2012, 56 ( 4 ) : 520-525. DOI : 10.1111/j. 1399-6576.2011.02628.x.
9Vanlander AV, Okun JG, de Jaeger A, et al. Possible patho- genic mechanism of propofol infusion syndrome involves coenzyme q[ J ]. Anesthesiology, 2015, 122 ( 2 ) : 343-352. DOI : 10. 1097/.
10ALN Fouad AA, Jresat I. Hepatoprotective effect of coenzyme QIO in rats with acetaminophen toxicity[ J]. Environ Toxicol Pharmacol, 2012,33(2) :158-167.DOI:10. 1016/j.etap.2011.12.011.
